At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
STTK Shattuck Labs, Inc.
Trading 04-29 10:25:40 EDT
11.19
+0.60
+5.67%
High11.40Low10.77Vol233.94K
Open10.77D1 Closing10.59Amplitude5.95%
Mkt Cap532.09MTradable Cap339.19MTotal Shares47.55M
T/O2.62MT/O Rate0.77%Tradable Shares30.31M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--
Owning 36% shares,institutional owners seem interested in Shattuck Labs, Inc. (NASDAQ:STTK),
Simply Wall St.  ·  04-18
Owning 36% shares,institutional owners seem interested in Shattuck Labs, Inc. (NASDAQ:STTK),
Analysts Offer Insights on Healthcare Companies: Shattuck Labs (STTK) and Verastem (VSTM)
TIPRANKS  ·  04-12
Analysts Offer Insights on Healthcare Companies: Shattuck Labs (STTK) and Verastem (VSTM)
Analysts Conflicted on These Healthcare Names: Shattuck Labs (STTK), Johnson & Johnson (JNJ) and Tilray (TLRY)
TIPRANKS  ·  04-11
Analysts Conflicted on These Healthcare Names: Shattuck Labs (STTK), Johnson & Johnson (JNJ) and Tilray (TLRY)
Shattuck Labs Announces Oral Presentation of Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2024
GlobeNewswire  ·  04-09
Shattuck Labs Announces Oral Presentation of Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2024
Strong Buy Rating for Shattuck Labs on Innovative Immunotherapy Pipeline and Leadership
TIPRANKS  ·  04-09
Strong Buy Rating for Shattuck Labs on Innovative Immunotherapy Pipeline and Leadership
Shattuck Labs Announces Participation in Upcoming 23rd Annual Needham Virtual Healthcare Conference
GlobeNewswire  ·  04-01
Shattuck Labs Announces Participation in Upcoming 23rd Annual Needham Virtual Healthcare Conference
Shattuck Labs Full Year 2023 Earnings: Beats Expectations
Simply Wall St.  ·  03-06
Shattuck Labs Full Year 2023 Earnings: Beats Expectations
Shattuck Labs Boosts Board with Biotech Heavyweights
TIPRANKS  ·  03-04
Shattuck Labs Boosts Board with Biotech Heavyweights
BRIEF-Shattuck Labs Announces Appointment Of Clay Siegall And Kate Sasser To Its Board Of Directors
Reuters  ·  03-04
BRIEF-Shattuck Labs Announces Appointment Of Clay Siegall And Kate Sasser To Its Board Of Directors
Press Release: Shattuck Labs Announces Appointment of Clay Siegall, Ph.D., and Kate Sasser, Ph.D., to its Board of Directors
Dow Jones  ·  03-04
Press Release: Shattuck Labs Announces Appointment of Clay Siegall, Ph.D., and Kate Sasser, Ph.D., to its Board of Directors
Shattuck Labs Price Target Maintained With a $28.00/Share by HC Wainwright & Co.
Dow Jones  ·  03-01
Shattuck Labs Price Target Maintained With a $28.00/Share by HC Wainwright & Co.
Buy Rating Affirmed for Shattuck Labs on Promising Clinical Updates and Strong Financial Position
TIPRANKS  ·  03-01
Buy Rating Affirmed for Shattuck Labs on Promising Clinical Updates and Strong Financial Position
Buy Rating Justified: Shattuck Labs’ Breakthrough in Cancer Immunotherapy and Strong Financials
TIPRANKS  ·  03-01
Buy Rating Justified: Shattuck Labs’ Breakthrough in Cancer Immunotherapy and Strong Financials
Buy Rating Affirmed for Shattuck Labs on Strong Financials and Promising Clinical Trials
TIPRANKS  ·  03-01
Buy Rating Affirmed for Shattuck Labs on Strong Financials and Promising Clinical Trials
Shattuck Labs (STTK) Receives a Buy from TD Cowen
TIPRANKS  ·  03-01
Shattuck Labs (STTK) Receives a Buy from TD Cowen
Shattuck Labs Inc reports results for the quarter ended in December - Earnings Summary
Reuters  ·  03-01
Shattuck Labs Inc reports results for the quarter ended in December - Earnings Summary
Shattuck Labs Q4 EPS $(0.41) Beats $(0.57) Estimate
Benzinga  ·  03-01
Shattuck Labs Q4 EPS $(0.41) Beats $(0.57) Estimate
BRIEF-Shattuck Labs Q4 Net Income USD -17.687 Million
Reuters  ·  03-01
BRIEF-Shattuck Labs Q4 Net Income USD -17.687 Million
Shattuck Labs Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights
GlobeNewswire  ·  03-01
Shattuck Labs Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights
Shattuck Labs Announces Participation in Upcoming March Conferences
GlobeNewswire  ·  02-26
Shattuck Labs Announces Participation in Upcoming March Conferences

Introduction

Company Name.
Shattuck Labs, Inc.
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. The company was incorporated in 2016 and is headquartered in Austin, Texas.
Issue price:
--